@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix chebi: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:96765; a Protein: . sub:_2 occursIn: obo:UBERON_0001969, species:10090; rdf:object chebi:41564; rdf:predicate belv:decreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(MGI:Ldlr) -| a(CHEBI:cholesterol)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "LDL receptor levels are subject to negative feedback regulation by cellular cholesterol through Srebf2 Srebf2 gene is regulated by thyroid hormone and that increased Srebf2 nuclear protein levels in hypothyroid animals results in thyroid hormone independent activation of LDL receptor gene expression and reversal of the associated hypercholesterolemia the decreased LDL receptor and increased serum cholesterol associated with hypothyroidism is secondary to the thyroid hormone effects on Srebf2"; prov:wasQuotedFrom pubmed:12829694 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12829694; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:03.772+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }